Notably, reducing WDHD1 expression has been shown to hinder the process of epithelial–mesenchymal transition (EMT) and the spread of cancer cells to lymph nodes in CCA, making it a potential target for CCA treatment [20]. The gene discussed is WDHD1; the disease is cholangiocarcinoma.